Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220

Metabolic & Incretin Research

Single, dual, and triple incretin receptor agonists (GLP-1R, GIPR, GCGR), amylin analogues, and AMPK/NNMT metabolic reference compounds.

≥99.0%
5-Amino-1MQ 10 mg — ≥99.0% Research Vial
5-Amino-1MQ
10 mg In stock
CAS 42464-96-0
MW: 286.11 g/mol
€58
≥99.0%
Adipotide 5 mg — ≥99.0% Research Vial
Adipotide
5 mg In stock
CAS 859216-15-2
MW: 2555.20 g/mol
€55
≥99.0%
AICAR 50 mg — ≥99.0% Research Vial
AICAR
50 mg In stock
CAS 2627-69-2
MW: 258.23 g/mol
€48
≥99.0%
AOD-9604 5 mg — ≥99.0% Research Vial
AOD-9604
5 mg In stock
CAS 221231-10-3
MW: 1815.08 g/mol
€44
≥99.0%
Cagrilintide 5 mg — ≥99.0% Research Vial
Cagrilintide
5 mg In stock
CAS 1415456-99-3
MW: 4409.04 g/mol
€64
≥99.0%
Lemon Bottle 10 ml — ≥99.0% Research Vial
Lemon Bottle
10 ml In stock
CAS 83-88-5 / 8002-43-5 / 9001-00-7
MW: Multi-component enzymatic solution
€44
≥99.0%
Mazdutide 5 mg — ≥99.0% Research Vial
Mazdutide
5 mg In stock
CAS 2259884-03-0
MW: 4563.06 g/mol
€78
≥99.2%
Retatrutide 10 mg — ≥99.2% Research Vial
Retatrutide
10 mg In stock
CAS 2381089-83-2
MW: 4731.33 g/mol
€92
≥99.2%
Semaglutide 5 mg — ≥99.2% Research Vial
Semaglutide
5 mg In stock
CAS 910463-68-2
MW: 4113.58 g/mol
€62
≥99.0%
SLU-PP-332 5 mg — ≥99.0% Research Vial
SLU-PP-332
5 mg In stock
CAS 303760-60-3
MW: 290.32 g/mol
€66
≥99.0%
Survodutide 5 mg — ≥99.0% Research Vial
Survodutide
5 mg In stock
CAS 2805997-46-8
MW: 4231.65 g/mol
€82
≥99.2%
Tirzepatide 10 mg — ≥99.2% Research Vial
Tirzepatide
10 mg In stock
CAS 2023788-19-2
MW: 4813.45 g/mol
€76
Analytical Pathway Scope

Scientific Overview: Metabolic & Incretin Research

Our Metabolic & Incretin Research catalog spans next-generation acylated polypeptide agonists targeting GLP-1R (Semaglutide), dual GLP-1R/GIPR (Tirzepatide), dual GLP-1R/GCGR (Survodutide, Mazdutide), triple GLP-1R/GIPR/GCGR (Retatrutide), and calcitonin/amylin receptors (Cagrilintide), alongside non-peptide metabolic probes such as 5-Amino-1MQ, AICAR, and SLU-PP-332.

Acylated incretins (31–39 amino acids with C18/C20 fatty-diacid albumin linkers) require strict thermal control and high-resolution ESI-MS verification to confirm full side-chain acylation without truncation or deamidation byproducts.

Primary Research Mechanisms

  • GLP-1, GIP, and Glucagon GPCR agonism
  • Fatty-diacid albumin binding & extended half-life kinetics
  • AMPK, ERRα/β/γ, and NNMT cellular energy pathways
  • Lipolytic hGH fragment 176–191 models

Related Metabolic & Incretin Research Monographs

Metabolic & Incretin Research — Technical FAQ

Why do acylated incretin peptides require cold-chain logistics?

Long-chain acylated GLP-1/GIP/glucagon analogues contain fatty-diacid side chains and labile residues susceptible to deamidation and aggregation at elevated temperatures. SwissLab dispatches all metabolic vials in insulated thermal packaging.

How should hydrophobic metabolic compounds like AOD-9604 or SLU-PP-332 be solubilized?

While standard incretin salts dissolve in sterile water or buffered saline (pH 7.4), hydrophobic compounds such as AOD-9604 may require initial dissolution in 0.6% sterile acetic acid, and small-molecule ERR agonists like SLU-PP-332 require sterile DMSO stock preparation.

Do small-molecule metabolic probes like 5-Amino-1MQ use peptide Net Peptide Content math?

No. 5-Amino-1MQ is a quaternary quinolinium iodide salt (~44.3% iodide mass by weight), so molarity calculations should correct for the iodide counterion mass rather than polypeptide TFA/acetate NPC factors.

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog